Business Description
Illumina Inc
NAICS : 621511
SIC : 8071
ISIN : BRI1LMBDR007
Share Class Description:
BSP:I1LM34: BRDRTotal Employee Number:
8,650Compare
Compare
Traded in other countries / regions
ILMN.USA0J8Z.UKILMN.MexicoILU.GermanyI1LM34.BrazilILMN.Austria1ILMN.ItalyILMN.Switzerland IPO Date
2020-01-27Description
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.43 | |||||
Debt-to-Equity | 0.89 | |||||
Debt-to-EBITDA | 1.83 | |||||
Interest Coverage | 9.01 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.15 | |||||
Beneish M-Score | -2.67 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.6 | |||||
3-Year EPS without NRI Growth Rate | 31.7 | |||||
3-Year FCF Growth Rate | 106.8 | |||||
3-Year Book Growth Rate | -24.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 12.88 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 6.37 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 74.28 | |||||
9-Day RSI | 71.5 | |||||
14-Day RSI | 70.67 | |||||
3-1 Month Momentum % | 40.91 | |||||
6-1 Month Momentum % | 38.27 | |||||
12-1 Month Momentum % | 85.77 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.8 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 0.74 | |||||
Days Inventory | 143.53 | |||||
Days Sales Outstanding | 61.51 | |||||
Days Payable | 53.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.1 | |||||
Shareholder Yield % | 1.93 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 66.39 | |||||
Operating Margin % | 19.85 | |||||
Net Margin % | 18.36 | |||||
EBITDA Margin % | 30.83 | |||||
FCF Margin % | 20.8 | |||||
OCF Margin % | 24.46 | |||||
ROE % | 32.04 | |||||
ROA % | 12.84 | |||||
ROIC % | 15.24 | |||||
3-Year ROIIC % | -4.82 | |||||
ROC (Joel Greenblatt) % | 63.22 | |||||
ROCE % | 23.22 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 8 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 36.97 | |||||
Forward PE Ratio | 37.65 | |||||
PE Ratio without NRI | 38.48 | |||||
Price-to-Owner-Earnings | 36.59 | |||||
PS Ratio | 6.77 | |||||
PB Ratio | 10.56 | |||||
Price-to-Tangible-Book | 26.2 | |||||
Price-to-Free-Cash-Flow | 32.68 | |||||
Price-to-Operating-Cash-Flow | 27.78 | |||||
EV-to-EBIT | 28.13 | |||||
EV-to-Forward-EBIT | 31.37 | |||||
EV-to-EBITDA | 22.61 | |||||
EV-to-Forward-EBITDA | 24.63 | |||||
EV-to-Revenue | 6.96 | |||||
EV-to-Forward-Revenue | 6.93 | |||||
EV-to-FCF | 33.6 | |||||
Price-to-GF-Value | 1.5 | |||||
Price-to-Projected-FCF | 4.05 | |||||
Price-to-Median-PS-Value | 0.65 | |||||
Price-to-Graham-Number | 6.69 | |||||
Earnings Yield (Greenblatt) % | 3.56 | |||||
FCF Yield % | 3.12 | |||||
Forward Rate of Return (Yacktman) % | -2.34 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Illumina Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 23,780.974 | ||
| EPS (TTM) (R$) | 5.702 | ||
| Beta | -0.1175 | ||
| 3-Year Sharpe Ratio | 0.26 | ||
| 3-Year Sortino Ratio | 0.45 | ||
| Volatility % | 51.17 | ||
| 14-Day RSI | 70.67 | ||
| 14-Day ATR (R$) | 2.516712 | ||
| 20-Day SMA (R$) | 196.7575 | ||
| 12-1 Month Momentum % | 85.77 | ||
| 52-Week Range (R$) | 99.8 - 207.1 | ||
| Shares Outstanding (Mil) | 755 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Illumina Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Illumina Inc Stock Events
| Event | Date | Price (R$) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-05 16:30 | In 185 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-05 | In 184 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-30 16:30 | In 87 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 86 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 16:30 | 194.74 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-07-30 | 194.74 (+0.00%) | ||
| General meeting for 2025 | 2026-05-21 10:00 | 141.27 (-0.65%) | ||
| First quarter earnings conference call for 2026 | 2026-04-30 16:30 | 127.28 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-30 | 127.28 (+0.00%) | ||
| TD Cowen 46th Annual Health Care Conference | 2026-03-03 12:10 | 135.11 (+0.00%) |
Show
Entries
Illumina Inc Frequently Asked Questions
What is Illumina Inc(BSP:I1LM34)'s stock price today?
The current price of BSP:I1LM34 is R$205.17. The 52 week high of BSP:I1LM34 is R$207.10 and 52 week low is R$99.80.
When is next earnings date of Illumina Inc(BSP:I1LM34)?
The next earnings date of Illumina Inc(BSP:I1LM34) is 2026-10-30 Est..
Does Illumina Inc(BSP:I1LM34) pay dividends? If so, how much?
Illumina Inc(BSP:I1LM34) does not pay dividend.
Press Release
Articles on Illumina Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers